PPP1R1B and Huntington disease: Striatal tissues collected at endpoint showed that pS6 and the striatal medium spiny neuron [MSN] marker DARPP-32 were significantly elevated in tissues from NV-5297-treated HD mice compared to controls, indicating mTORC1 activation and improved striatal health (Fig 3A and 3B).